MoonLake Immunotherapeutics (MLTX) Insider Trading & Ownership $39.84 +1.45 (+3.78%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$39.84 -0.01 (-0.01%) As of 03/27/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MoonLake Immunotherapeutics (NASDAQ:MLTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.02%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$9.19 M Get MLTX Insider Trade Alerts Want to know when executives and insiders are buying or selling MoonLake Immunotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MLTX Insider Buying and Selling by Quarter Remove Ads MoonLake Immunotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/4/2024Simon SturgeDirectorSell171,000$53.72$9,186,120.00 (Data available from 1/1/2013 forward) MLTX Insider Trading Activity - Frequently Asked Questions Who is on MoonLake Immunotherapeutics's Insider Roster? The list of insiders at MoonLake Immunotherapeutics includes Bihua Chen, Da Silva Jorge Santos, Kristian Reich, Matthias Bodenstedt, and Simon Sturge. Learn more on insiders at MLTX. What percentage of MoonLake Immunotherapeutics stock is owned by insiders? 12.02% of MoonLake Immunotherapeutics stock is owned by insiders. Learn more on MLTX's insider holdings. Which MoonLake Immunotherapeutics insiders have been buying company stock? The following insider purchased MLTX shares in the last 24 months: Bihua Chen ($68,718,242.55). How much insider buying is happening at MoonLake Immunotherapeutics? Insiders have purchased a total of 1,392,725 MLTX shares in the last 24 months for a total of $68,718,242.55 bought. Which MoonLake Immunotherapeutics insiders have been selling company stock? The following insiders have sold MLTX shares in the last 24 months: Da Silva Jorge Santos ($6,071,868.60), Kristian Reich ($3,418,805.00), Matthias Bodenstedt ($5,610,265.92), and Simon Sturge ($9,186,120.00). How much insider selling is happening at MoonLake Immunotherapeutics? Insiders have sold a total of 432,717 MoonLake Immunotherapeutics shares in the last 24 months for a total of $24,287,059.52 sold. MoonLake Immunotherapeutics Key ExecutivesDr. Jorge Santos da Silva (Age 46)Co-Founder, CEO & Director Compensation: $1.11MDr. Kristian Reich (Age 58)Co-Founder & Chief Scientific Officer Compensation: $1.2MMr. Matthias Bodenstedt (Age 36)Chief Financial Officer Compensation: $588.25kMr. Oliver DaltropChief Technical OfficerNicolas MosimannGeneral CounselLuciana MarquesDirector of HR, People & CultureMs. Nuala BrennanChief Clinical Development Officer More Insider Trading Tools from MarketBeat Related Companies PCVX Insider Trading ROIV Insider Trading SRPT Insider Trading RVMD Insider Trading LNTH Insider Trading TGTX Insider Trading BBIO Insider Trading AXSM Insider Trading BPMC Insider Trading KRYS Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:MLTX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MoonLake Immunotherapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share MoonLake Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLTX Stock Free MLTX Stock Alerts